| 161 |
Modified Lidocaine Derivatives as a Potential Inhibitors of Eosinophils |
2018 |
| 162 |
Novel 1,2,4-triazole derivatives as potential anticancer agents: Design, synthesis, molecular docking and mechanistic studies |
2018 |
| 163 |
Novel N-Substituted 5-aminosalicylamides as Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase Enzymes: Synthesis, Biological Evaluation and Docking Study |
2018 |
| 164 |
Novel N-Substituted 5-aminosalicylamides as Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase Enzymes: Synthesis, Biological Evaluation and Docking Study |
2018 |
| 165 |
Novel N-Substituted 5-aminosalicylamides as Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase Enzymes: Synthesis, Biological Evaluation and Docking Study |
2018 |
| 166 |
Novel N-Substituted 5-aminosalicylamides as Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase Enzymes: Synthesis, Biological Evaluation and Docking Study |
2018 |
| 167 |
Novel Pyrrol-2(3H)-ones and Pyridazin-3(2H)-ones Carrying Quinoline Scaffold as Anti-Proliferative Tubulin Polymerization Inhibitors |
2018 |
| 168 |
Proximity Labeling of Cis-Ligands of CD22/Siglec-2 Reveals Stepwise 2,6 Sialic Acid-Dependent and -Independent Interactions |
2018 |
| 169 |
Synthesis and In Vitro Antiproliferative Activity of New 1-Phenyl-3-(4-(pyridin-3-yl)phenyl)urea Scaffold-Based Compounds |
2018 |
| 170 |
Synthesis, Anticancer Activity and Molecular Modeling Studies of 1,2,4-Triazole Derivatives as EGFR Inhibitors |
2018 |
